These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

318 related items for PubMed ID: 17598405

  • 21. [Comparison of the in vitro activity of ceftazidime: in culture, in serum and in combination with granulocytes].
    Daschner FD, Bassler M, Grundau D, Dieterle L, Just HM.
    Immun Infekt; 1983 Nov; 11(6):221-8. PubMed ID: 6439624
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. [Comparative bactericidal activity of cefsulodin and ceftazidime on Pseudomonas aeruginosa].
    Delisle-Mizon F, Lesage D, Denis C, Vergez P, Daguet GL.
    Pathol Biol (Paris); 1983 May; 31(5):383-6. PubMed ID: 6413938
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. In vitro susceptibility pattern of cephalosporin-resistant Gram-negative bacteria.
    Punpanich W, Tantichattanon W, Wongwatcharapaiboon S, Treeratweeraphong V.
    J Med Assoc Thai; 2008 Oct; 91 Suppl 3():S21-7. PubMed ID: 19255989
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Comparative in vitro interactions of ceftazidime, meropenem, and imipenem with amikacin on multiresistant Pseudomonas aeruginosa.
    Giamarellos-Bourboulis EJ, Grecka P, Giamarellou H.
    Diagn Microbiol Infect Dis; 1997 Oct; 29(2):81-6. PubMed ID: 9368083
    [Abstract] [Full Text] [Related]

  • 30. Alginate lyase enhances antibiotic killing of mucoid Pseudomonas aeruginosa in biofilms.
    Alkawash MA, Soothill JS, Schiller NL.
    APMIS; 2006 Feb; 114(2):131-8. PubMed ID: 16519750
    [Abstract] [Full Text] [Related]

  • 31. Use of breakpoint combination sensitivity testing as a simple and convenient method to evaluate the combined effects of ceftazidime and tobramycin on Pseudomonas aeruginosa and Burkholderia cepacia complex isolates in vitro.
    Tunney MM, Scott EM.
    J Microbiol Methods; 2004 Apr; 57(1):107-14. PubMed ID: 15003693
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Development of Antibiotic Resistance during Simulated Treatment of Pseudomonas aeruginosa in Chemostats.
    Feng Y, Hodiamont CJ, van Hest RM, Brul S, Schultsz C, Ter Kuile BH.
    PLoS One; 2016 Apr; 11(2):e0149310. PubMed ID: 26872140
    [Abstract] [Full Text] [Related]

  • 34. Susceptibility of Pseudomonas aeruginosa to serum bactericidal activity. A comparison of three methods with clinical correlations.
    DeMatteo CS, Hammer MC, Baltch AL, Smith RP, Sutphen NT, Michelsen PB.
    J Lab Clin Med; 1981 Oct; 98(4):511-8. PubMed ID: 6793679
    [Abstract] [Full Text] [Related]

  • 35. Optimization of therapy against Pseudomonas aeruginosa with ceftazidime and meropenem using chemostats as model for infections.
    Feng Y, Bakker RT, van Hest RM, Hodiamont CJ, Brul S, Schultsz C, Ter Kuile BH.
    FEMS Microbiol Lett; 2017 Aug 01; 364(14):. PubMed ID: 28854670
    [Abstract] [Full Text] [Related]

  • 36. Investigation of synergism of meropenem and ciprofloxacin against Pseudomonas aeruginosa and Acinetobacter strains isolated from intensive care unit infections.
    Ermertcan S, Hoşgör M, Tünger O, Coşar G.
    Scand J Infect Dis; 2001 Aug 01; 33(11):818-21. PubMed ID: 11760161
    [Abstract] [Full Text] [Related]

  • 37. Antimicrobial activity of commonly used antibiotics and DNA fingerprint analysis of Pseudomonas aeruginosa obtained from clinical isolates and unchlorinated drinking water in Korea, 2010.
    Kim JR, Lee DK, An HM, Kim MJ, Lee SW, Cha MK, Lee KO, Ha NJ.
    Arch Pharm Res; 2011 Aug 01; 34(8):1353-61. PubMed ID: 21910058
    [Abstract] [Full Text] [Related]

  • 38. [Bactericidal activity of biapenem against various efflux system mutants of Pseudomonas aeruginosa].
    Hiraishi T, Miyata A, Takata T, Araake M, Ogawa H, Gotoh N, Nishino T.
    Jpn J Antibiot; 2002 Feb 01; 55(1):67-76. PubMed ID: 11977922
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.